FineMark National Bank & Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,700
Closed -$35K 1032
2016
Q4
$35K Sell
1,700
-6,800
-80% -$140K ﹤0.01% 707
2016
Q3
$138K Buy
8,500
+7,500
+750% +$122K 0.01% 386
2016
Q2
$14K Hold
1,000
﹤0.01% 890
2016
Q1
$17K Hold
1,000
﹤0.01% 807
2015
Q4
$34K Sell
1,000
-1,000
-50% -$34K ﹤0.01% 711
2015
Q3
$60K Hold
2,000
0.01% 574
2015
Q2
$64K Hold
2,000
0.01% 588
2015
Q1
$41K Hold
2,000
0.01% 721
2014
Q4
$34K Hold
2,000
0.01% 777
2014
Q3
$39K Buy
+2,000
New +$39K 0.01% 703